• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检测阴性研究中“总体疫苗效力”的因果解释

The Causal Interpretation of "Overall Vaccine Effectiveness" in Test-Negative Studies.

作者信息

Feng Shuo, Sullivan Sheena G, Tchetgen Tchetgen Eric J, Cowling Benjamin J

出版信息

Am J Epidemiol. 2021 Oct 1;190(10):1993-1999. doi: 10.1093/aje/kwab101.

DOI:10.1093/aje/kwab101
PMID:33831173
Abstract

Test-negative studies are commonly used to estimate influenza vaccine effectiveness (VE). In a typical study, an "overall VE" estimate based on data from the entire sample may be reported. However, there may be heterogeneity in VE, particularly by age. Therefore, in this article we discuss the potential for a weighted average of age-specific VE estimates to provide a more meaningful measure of overall VE. We illustrate this perspective first using simulations to evaluate how overall VE would be biased when certain age groups are overrepresented. We found that unweighted overall VE estimates tended to be higher than weighted VE estimates when children were overrepresented and lower when elderly persons were overrepresented. Then we extracted published estimates from the US Flu VE network, in which children are overrepresented, and some discrepancy between unweighted and weighted overall VE was observed. Differences in weighted versus unweighted overall VE estimates could translate to substantial differences in the interpretation of individual risk reduction among vaccinated persons and in the total averted disease burden at the population level. Weighting of overall estimates should be considered in VE studies in the future.

摘要

检测呈阴性的研究通常用于估计流感疫苗的有效性(VE)。在一项典型研究中,可能会报告基于整个样本数据的“总体VE”估计值。然而,VE可能存在异质性,尤其是按年龄划分。因此,在本文中,我们讨论了按年龄划分的VE估计值加权平均以提供更有意义的总体VE衡量指标的可能性。我们首先通过模拟来说明这一观点,以评估当某些年龄组占比过高时总体VE会如何产生偏差。我们发现,当儿童占比过高时,未加权的总体VE估计值往往高于加权VE估计值;而当老年人占比过高时,未加权的总体VE估计值则较低。然后,我们从美国流感VE网络中提取了已发表的估计值,该网络中儿童占比过高,并且观察到未加权和加权总体VE之间存在一些差异。加权与未加权总体VE估计值的差异可能会导致在接种疫苗人群个体风险降低的解释以及人群层面避免的疾病总负担方面产生重大差异。未来在VE研究中应考虑对总体估计值进行加权。

相似文献

1
The Causal Interpretation of "Overall Vaccine Effectiveness" in Test-Negative Studies.检测阴性研究中“总体疫苗效力”的因果解释
Am J Epidemiol. 2021 Oct 1;190(10):1993-1999. doi: 10.1093/aje/kwab101.
2
Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis.利用替代对照组的阴性测试设计估计流感疫苗有效性:系统评价和荟萃分析。
Am J Epidemiol. 2018 Feb 1;187(2):389-397. doi: 10.1093/aje/kwx251.
3
Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study.在流感疫苗效力常规监测中,频率派推断与贝叶斯推断的差异:一项病例对照研究。
BMC Public Health. 2021 Mar 16;21(1):516. doi: 10.1186/s12889-021-10543-z.
4
Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016-2017 Season: Insights Into Novel Age-Specific Analysis.2016-2017 年以色列初级保健中季节性流感疫苗预防实验室确诊流感的效果:新型年龄特异性分析的见解。
Clin Infect Dis. 2018 Apr 17;66(9):1383-1391. doi: 10.1093/cid/cix1013.
5
Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.早期季节性流感疫苗效力估计 - 美国,2015 年 1 月。
MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):10-5.
6
Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.德国应用筛查方法监测老年人流感疫苗的有效性。
BMC Infect Dis. 2015 Mar 20;15:137. doi: 10.1186/s12879-015-0882-3.
7
Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016.2011-2016 年美国流感疫苗有效性网络中门诊患者的流感疫苗有效性按研究地点划分。
Influenza Other Respir Viruses. 2020 Jul;14(4):380-390. doi: 10.1111/irv.12741. Epub 2020 Apr 16.
8
Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016.2012-2016 年美国高危医疗条件患者的流感疫苗有效性。
Vaccine. 2018 Dec 18;36(52):8047-8053. doi: 10.1016/j.vaccine.2018.10.093. Epub 2018 Nov 9.
9
The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings.住院环境中流感疫苗有效性研究的病例检测阴性设计。
Int J Epidemiol. 2016 Dec 1;45(6):2052-2059. doi: 10.1093/ije/dyw022.
10
Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings.采用检测阴性设计的流感疫苗效力——住院与门诊环境的比较。
Vaccine. 2016 Mar 29;34(14):1672-9. doi: 10.1016/j.vaccine.2016.02.039. Epub 2016 Feb 23.

引用本文的文献

1
Severity-dependent test-seeking behaviors and test-negative designs: impact on estimated vaccine effectiveness and utility of analytic and design choices.严重程度依赖的检测寻求行为和检测阴性设计:对估计的疫苗有效性以及分析和设计选择的效用的影响。
Am J Epidemiol. 2024 Aug 27;194(7):1855-62. doi: 10.1093/aje/kwae303.
2
Seasonal Influenza Vaccine Effectiveness in Persons Aged 15-64 Years: A Systematic Review and Meta-Analysis.15至64岁人群中季节性流感疫苗的有效性:一项系统评价与荟萃分析
Vaccines (Basel). 2023 Aug 4;11(8):1322. doi: 10.3390/vaccines11081322.